Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling

被引:17
作者
Bogaards, JJP [1 ]
Freidig, AP [1 ]
van Bladeren, PJ [1 ]
机构
[1] TNO, Nutr & Food Res, Div Toxicol, NL-3700 AJ Zeist, Netherlands
关键词
isoprene; metabolism; cytochrome P450; glutathione S-transferase; epoxide hydrolase; PBPK modelling;
D O I
10.1016/S0009-2797(01)00276-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was designed to explain the differences in isoprene toxicity between mouse and rat based on the liver concentrations of the assumed toxic metabolite isoprene diepoxide. In addition, extrapolation to the human situation was attempted. For this purpose, enzyme kinetic parameters K-m and V-max were determined in vitro in mouse, rat and human liver microsomes/cytosol for the cytochrome P450-mediated formation of isoprene mono- and diepoxides, epoxide hydrolase mediated hydrolysis of isoprene mono- and diepoxides, and the glutathione S-transferases mediated conjugation of isoprene monoepoxides. Subsequently, the kinetic parameters were incorporated into a physiologically-based pharmacokinetic model, and species differences regarding isoprene diepoxide levels were forecasted. Almost similar isoprene diepoxide liver and lung concentrations were predicted in mouse and rat, while predicted levels in humans were about 20-fold lower. However, when interindividual variation in enzyme activity was introduced in the human model, the levels of isoprene diepoxide changed considerably. It was forecasted that in individuals having both an extensive oxidation by cytochrome P450 and a low detoxification by epoxide hydrolase, isoprene diepoxide concentrations in the liver increased to similar concentrations as predicted for the mouse. However, the interpretation of the latter finding for human risk assessment is ambiguous since species differences between mouse and rat regarding isoprene toxicity could not be explained by the predicted isoprene diepoxide concentrations. We assume that other metabolites than isoprene diepoxide or different carcinogenic response might play a key role in determining the extent of isoprene toxicity. In order to confirm this, in vivo experiments are required in which isoprene epoxide concentrations will be established in rats and mice. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 265
页数:19
相关论文
共 29 条
[1]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[2]   The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes [J].
Bogaards, JJP ;
Venekamp, JC ;
vanBladeren, PJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 102 (03) :169-182
[3]   Conjugation of isoprene monoepoxides with glutathione, catalyzed by α, μ, π and θ-class glutathione S-transferases of rat and man [J].
Bogaards, JJP ;
Venekamp, JC ;
Salmon, FGC ;
van Bladeren, PJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 117 (01) :1-14
[4]   Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling [J].
Bogaards, JJP ;
Hissink, EM ;
Briggs, M ;
Weaver, R ;
Jochemsen, R ;
Jackson, P ;
Bertrand, M ;
van Bladeren, PJ .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) :117-124
[5]   DISPOSITION OF INHALED ISOPRENE IN B6C3F1 MICE [J].
BOND, JA ;
BECHTOLD, WE ;
BIRNBAUM, LS ;
DAHL, AR ;
MEDINSKY, MA ;
SUN, JD ;
HENDERSON, RF .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 107 (03) :494-503
[6]   The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 141 (02) :617-627
[7]   Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Sumner, SCJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 136 (02) :307-316
[8]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[9]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[10]   ISOPRENE METABOLISM BY LIVER MICROSOMAL MONOOXYGENASES [J].
DELMONTE, M ;
CITTI, L ;
GERVASI, PG .
XENOBIOTICA, 1985, 15 (07) :591-597